Evidence map›Paper›PMID 40387308›Full record

ReviewCancer reports (Hoboken, N.J.)2025

The Interplay of Chronic Stress and Cancer: Pathophysiology and Implications for Integrated Care.

Joyeeta Talukdar, Megha, Hemant Choudhary, Sushma Bhatnagar, Anuja Pandit, Ashwani Kumar Mishra, Subhradip Karmakar, Pratap Sharan

Abstract readReview
In one paragraph

Review in Cancer reports (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Hemostasis at the edge between physiology and cancer.Internal and emergency medicine · 2026
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joyeeta TalukdarDepartment of Bio-Chemistry, All India Institute of Medical Sciences, New Delhi, India.
MeghaDepartment of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.ORCID 0009-0008-7081-6386
Hemant ChoudharyDepartment of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.
Sushma BhatnagarDepartment of Onco-Anaesthesia & Palliative Medicine, DR. B.R.A.I.R.C.H, All India Institute of Medical Sciences, New Delhi, India.
Anuja PanditDepartment of Onco-Anaesthesia & Palliative Medicine, DR. B.R.A.I.R.C.H, All India Institute of Medical Sciences, New Delhi, India.
Ashwani Kumar MishraNational Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.
Subhradip KarmakarDepartment of Bio-Chemistry, All India Institute of Medical Sciences, New Delhi, India.
Pratap SharanDepartment of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.ORCID 0000-0003-2437-6099

Funding

Department of Health Research DHR-1534
6 · The paper itself

Abstract

backgroundCancer-associated depression is a multifaceted condition that arises from the interplay of biological, psychological, and social factors in individuals diagnosed with cancer. Understanding this condition involves exploring how cancer and its treatments can precipitate depressive symptoms and the mechanisms behind this association. Chronic stress, inflammation, and immunological responses play a crucial role in the development of both cancer and depression. The objective of this review is to describe and synthesize information on the complex interactions between chronic stress, inflammation, immunological responses, and cancer development. Additionally, it aims to review existing evidence regarding mechanisms such as neurotransmitter imbalances, structural brain changes, and genetic predispositions as key contributors to depression in cancer patients. RECENT

findingsA comprehensive literature search on Cancer-associated Depression was conducted in electronic databases, including APA PsycINFO, Medline, Google Scholar, Embase, PubMed, Scopus, and Web of Science. The research focused on understanding the potential relationship between stress-induced depression and cancer by examining neurochemical, anatomical, immunological, genetic, and psychological changes. The findings revealed a compilation of both quantitative and qualitative studies on depression in cancer patients. Evidence suggested a potential link between cancer-induced stress and depression, with increased levels of proinflammatory cytokines (such as IL-6) and dysregulation of neurotransmitters, including serotonin, contributing to the onset of depression. Furthermore, studies indicated that antidepressants, along with psychological interventions, were effective in managing depression among cancer patients.

conclusionThis narrative review provides insights into the importance of integrating oncology and mental health services to address the psychosocial needs of cancer patients. Future research should focus on the bidirectional interactions between stress and cancer, aiming to improve cancer care by incorporating mental health support. Addressing the mental health aspects of cancer treatment can significantly enhance patient outcomes and overall quality of life.

Indexed as

DepressionNeoplasmsStress, PsychologicalChronic DiseaseDelivery of Health Care, IntegratedHumansInflammationcancercancer stem cellschronic stresscounsellingdepressionimmune modulationpalliative carepsychiatrypsycho‐oncologypsychotherapy

Identifiers

PMID40387308
PMCPMC12087007

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.